ATH 0.00% 0.5¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-43

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93
    Thats right Pixie, its farcical, if FDA was truly worried about safety in dogs, we would have never made it to phase 2 trials in the first place...the trial sequence has been turned upside down for us .. Animal studies became more important AFTER a batch of human trials. The FDA is a joke.

    I dont see anywhere in their approval sequence on their webpage where animal studies need to be done after phase 2 leading into phase 3
    Last edited by pierre77: 19/08/16
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 122248 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 25307592 14
View Market Depth
Last trade - 16.12pm 16/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.